A. Ari Hakimi

29.6k citations

229 papers · 8.3k indexed · 3 hit papers · h-index 45

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis

Papers in

Cancer Research 91
- Cancer Genomics and Diagnostics 77
Pulmonary and Respiratory Medicine 189
- Renal cell carcinoma treatment 169
- Ferroptosis and cancer prognosis 20

Co-authors: Paul Russo James J. Hsieh Martin H. Voss Robert J. Motzer Timothy A. Chan Victor E. Reuter Satish K. Tickoo Chris Sander
Journals: Journal of Clinical Oncology (38 papers)The Journal of Urology (33 papers)Urologic Oncology Seminars and Original Investigations (15 papers)Urology (12 papers)European Urology (8 papers)
Partner nations: United States Germany Australia

In The Last Decade

A. Ari Hakimi

221 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma 2019 · 293 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cancer Discovery
2016 JCI Insight
2016 Cancer Cell

Peers

Countries citing papers authored by A. Ari Hakimi

Since Specialization

Citations

This map shows the geographic impact of A. Ari Hakimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ari Hakimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ari Hakimi more than expected).

Fields of papers citing papers by A. Ari Hakimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ari Hakimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ari Hakimi. The network helps show where A. Ari Hakimi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Ari Hakimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Ari Hakimi Line = papers co-authored together A. Ari Hakimi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma European Urology ·Lennert Eismann, Amy Xie, Cerise Tang, Andrea Knežević, Irina Ostrovnaya, Fengshen Kuo, A. Ari Hakimi, Ed Reznik, Ritesh R. Kotecha	2024	2
2	Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors Urologic Oncology Seminars and Original Investigations ·Sari Khaleel, Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram, Phillip M. Rappold, Ritesh R. Kotecha, Jonathan Coleman, Paul Russo, Robert J. Motzer, Ed Reznik, A. Ari Hakimi	2024	2
3	Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma Cancer Epidemiology Biomarkers & Prevention ·Patrick T. Bradshaw, Sang Hee 신상희Shin, Alejandro Sánchez, Andrea Knežević, Oğuz Akın, Jessica M. Scott, A. Ari Hakimi, Paul Russo, Bette J. Caan, Marina Mourtzakis, Helena Furberg	2024	0
4	Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study British Journal of Urology ·Kyle A. Blum, Andrew W. Silagy, Andrea Knežević, Stanley Weng, Alan Wang, Roy Mano, Julian Marcon, Renzo G. DiNatale, Alejandro Sánchez, Satish K. Tickoo, Sounak Gupta, Robert J. Motzer, Naomi B. Haas, Se Eun Kim, Robert G. Uzzo, Jonathan Coleman, A. Ari Hakimi, Paul Russo	2023	3
5	A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation Nature Metabolism ·Elisa Benedetti, Eric Minwei Liu, Cerise Tang, Fengshen Kuo, Mustafa Büyüközkan, Ιωάννα Αντωνίου Χατζημπαλιώτη, Jinsung Park, Fabian Correa, A. Ari Hakimi, Andrew M. Intlekofer, Jan Krumsiek, Ed Reznik	2023	27
6	Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade Clinical Cancer Research ·Yasser Ged, Alejandro Sánchez, Sujata Patil, Andrea Knežević, 堀内秀与, Stacey Petruzella, Kate Weiss, Shaimaa EL-Sayed Abdullah Ibrahim, Joshua Chaim, Oğuz Akın, Marina Mourtzakis, Michael T. Paris, Jessica M. Scott, Fengshen Kuo, Ritesh R. Kotecha, A. Ari Hakimi, Chung‐Han Lee, Robert J. Motzer, Martin H. Voss, Helena Furberg	2022	20
7	Genetics and Tumor Microenvironment of Renal Cell Carcinoma SHILAP Revista de lepidopterología ·Sari Khaleel, Christopher J. Ricketts, W. Marston Linehan, Mark W. Ball, Brandon J. Manley, Elsio Lenardão, James Brugarolas, A. Ari Hakimi	2022	1
8	Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma – An exploratory analysis Urologic Oncology Seminars and Original Investigations ·Roy Mano, Shaimaa EL-Sayed Abdullah Ibrahim, 邦博尾崎, Debra A. Goldman, Kyle A. Blum, Andrew W. Silagy, سلوى أحمد محمد أبوالعلا, Alejandro Sánchez, Renzo G. DiNatale, Julian Marcon, Epameinondas Paschos, Maria F. Becerra, Nicole Benfante, Jonathan Coleman, Michael W. Kattan, Paul Russo, Oğuz Akın, Irina Ostrovnaya, A. Ari Hakimi	2021	7
9	Endovascular management of a large renal artery aneurysm: a case report and review of the literature BMC Urology ·Samsara Soto, Peter H. Connolly, A. Ari Hakimi	2021	2
10	The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype Clinical Cancer Research ·Maximilian Linxweiler, Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin, Vladimir Makarov, Diego Chowell, Snjezana Doğan, Ian Ganly, A. Ari Hakimi, Richard J. Wong, Nadeem Riaz, Alan L. Ho, Timothy A. Chan, Luc G.T. Morris	2020	79
11	Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival Cancer Research ·Joseph R. Scarpa, Renzo G. DiNatale, Roy Mano, Andrew W. Silagy, Fengshen Kuo, 王加朋 Wang Jiapeng, Patrick J. McCormick, Gregory W. Fischer, A. Ari Hakimi, Joshua S. Mincer	2020	12
12	Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial Cancer Discovery ·A. Ari Hakimi, Martin H. Voss, Fengshen Kuo, Alejandro Sánchez, Ming Liu, Briana G. Nixon, Lynda Vuong, Irina Ostrovnaya, Ying‐Bei Chen, Victor E. Reuter, Nadeem Riaz, Yuan Cheng, Parul Patel, Mahtab Marker, Albert Reising, Ming O. Li, Timothy A. Chan, Robert J. Motzer	2019	156
13	The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy European Urology Oncology ·Renzo G. DiNatale, Wanling Xie, Maria F. Becerra, Andrew W. Silagy, Kyrollis Attalla, Alejandro Sánchez, Roy Mano, Julian Marcon, Kyle A. Blum, Nicole Benfante, Martin H. Voss, Robert J. Motzer, Jonathan Coleman, Toni K. Choueiri, Ed Reznik, Paul Russo, Daniel Y.C. Heng, A. Ari Hakimi	2019	19
14	Functional methylome analysis of human diabetic kidney disease JCI Insight ·Jihwan Park, Yuting Guan, Xin Sheng, Caroline Gluck, Matthew J. Seasock, A. Ari Hakimi, Chengxiang Qiu, James Pullman, Amit Verma, Hongzhe Li, Matthew Palmer, Katalin Suszták	2019	59
15	The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma Urologic Oncology Seminars and Original Investigations ·Roy Mano, Jessica Flynn, Kyle A. Blum, Andrew W. Silagy, Renzo G. DiNatale, Julian Marcon, Alan Wang, Alejandro Sánchez, Jonathan Coleman, Paul Russo, Irina Ostrovnaya, A. Ari Hakimi	2019	9
16	Rejection of immunogenic tumor clones is limited by clonal fraction eLife ·Ron S. Gejman, Aaron Y. Chang, Y-T Li, Stephan Forchhammer, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg	2018	79
17	Mitochondrial DNA copy number variation across human cancers eLife ·Ed Reznik, Martin L. Miller, Yasin Şenbabaoğlu, Nadeem Riaz, Judy Sarungbam, Satish K. Tickoo, Hikmat Al‐Ahmadie, William Lee, Venkatraman Seshan, A. Ari Hakimi, Chris Sander	2016	376
18	Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis Cancer Research ·Hiromi I. Wettersten, A. Ari Hakimi, Dexter Morin, Cristina Bianchi, Megan Johnstone, Dallas R. Donohoe, Josephine F. Trott, Omran Abu Aboud, Steven M. Stirdivant, Bruce Neri, Robert L. Wolfert, Benjamin J. Stewart, R Perego, James J. Hsieh, Robert H. Weiss	2015	226
19	Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy Clinical Cancer Research ·Martin H. Voss, A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying‐Bei Chen, Luis F. Cunha, Oğuz Akın, Han Liu, Shugaku Takeda, Sasinya N. Scott, Nicholas D. Socci, Agnès Viale, Nikolaus Schultz, Chris Sander, Victor E. Reuter, Paul Russo, Emily H. Cheng, Robert J. Motzer, Michael F. Berger, James J. Hsieh	2014	156
20	Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network Clinical Cancer Research ·A. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying‐Bei Chen, Mithat Gönen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer, James J. Hsieh	2013	267

About A. Ari Hakimi

A. Ari Hakimi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Surgery, having authored 229 papers that have together received 8.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (169 papers), Renal and related cancers (89 papers), Cancer Genomics and Diagnostics (77 papers), Bladder and Urothelial Cancer Treatments (47 papers), Cancer Immunotherapy and Biomarkers (23 papers), Ferroptosis and cancer prognosis (20 papers), Multiple and Secondary Primary Cancers (17 papers) and Epigenetics and DNA Methylation (16 papers). The work is most often cited by research in Cancer Research (2.9k citations), Pulmonary and Respiratory Medicine (4.9k citations), Oncology (2.1k citations), Molecular Biology (4.4k citations) and Otorhinolaryngology (171 citations). A. Ari Hakimi has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Paul Russo, James J. Hsieh, Martin H. Voss, Robert J. Motzer, Timothy A. Chan, Victor E. Reuter, Satish K. Tickoo, Chris Sander, Nadeem Riaz and Ying‐Bei Chen. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Urology and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact